As a potential Alzheimer medicine, betaine was tested on an AD animal model in a novel object recognition test. Using video tracking, scientists studied the influence of betaine and betaine transporter on mouse memory.
Scientists have found out that a low dose of the tranquilizer diazepam reduces the breakdown of neurons, seen in the development of Alzheimer’s disease.
During the annual Brain Awareness Week, international attention focuses on the brain to increase public awareness of the progress and benefits of brain research.
Experts estimate that by 2050, 100 million people will have Alzheimer’s disease (AD), which is a shockingly large number. Learn more about the research that has been done in order to find a cure.
Researcher Wendy Moyle and her team explored if the use of a robotic seal as a therapeutic tool would influence the emotional and behavioral symptoms of dementia.
Tailored Activity Programs (TAP) have been shown to have significantly reduce behavioral occurrences in dementia patients and improve engagement and positive behaviors.
Ataxia is a common problem in Parkinson’s disease (PD), and many early onset Alzheimer’s disease patients (AD) also deal with it. Now there is a non-invasive test for mouse models.
Alzheimer’s disease (AD) is a huge public health issue as it affects a large part of the aging population. Neuropathology is studied primarily in the end stages of the disease. What about prevention?
Xu Liu and colleagues recently investigated the effects of Ginkgo biloba extract on a mouse model for Alzheimer’s disease (AD).